These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 16762988

  • 1. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.
    Bernhardt WM, Câmpean V, Kany S, Jürgensen JS, Weidemann A, Warnecke C, Arend M, Klaus S, Günzler V, Amann K, Willam C, Wiesener MS, Eckardt KU.
    J Am Soc Nephrol; 2006 Jul; 17(7):1970-8. PubMed ID: 16762988
    [Abstract] [Full Text] [Related]

  • 2. The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment.
    Wang Z, Schley G, Türkoglu G, Burzlaff N, Amann KU, Willam C, Eckardt KU, Bernhardt WM.
    Nephrol Dial Transplant; 2012 Mar; 27(3):929-36. PubMed ID: 21742784
    [Abstract] [Full Text] [Related]

  • 3. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury.
    Jamadarkhana P, Chaudhary A, Chhipa L, Dubey A, Mohanan A, Gupta R, Deshpande S.
    Am J Nephrol; 2012 Mar; 36(3):208-18. PubMed ID: 22948183
    [Abstract] [Full Text] [Related]

  • 4. Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury.
    Yang Y, Yu X, Zhang Y, Ding G, Zhu C, Huang S, Jia Z, Zhang A.
    Clin Sci (Lond); 2018 Apr 16; 132(7):825-838. PubMed ID: 29581249
    [Abstract] [Full Text] [Related]

  • 5. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney.
    Rosenberger C, Rosen S, Shina A, Frei U, Eckardt KU, Flippin LA, Arend M, Klaus SJ, Heyman SN.
    Nephrol Dial Transplant; 2008 Nov 16; 23(11):3472-8. PubMed ID: 18515655
    [Abstract] [Full Text] [Related]

  • 6. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain.
    Jones NM, Lee EM, Brown TG, Jarrott B, Beart PM.
    Neurosci Lett; 2006 Aug 14; 404(1-2):72-7. PubMed ID: 16828226
    [Abstract] [Full Text] [Related]

  • 7. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ, Tian YM, Mole DR, Harris AL.
    Circ Res; 2004 Jul 23; 95(2):162-9. PubMed ID: 15192023
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C, Krischke G, Keller S, Walkinshaw G, Arend M, Rascher W, Gassmann M, Trollmann R.
    Brain Res; 2009 Jul 14; 1280():43-51. PubMed ID: 19450570
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury.
    Kapitsinou PP, Jaffe J, Michael M, Swan CE, Duffy KJ, Erickson-Miller CL, Haase VH.
    Am J Physiol Renal Physiol; 2012 May 01; 302(9):F1172-9. PubMed ID: 22262480
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS, Schofield CJ, Ratcliffe PJ.
    Methods Enzymol; 2007 May 01; 435():25-42. PubMed ID: 17998047
    [Abstract] [Full Text] [Related]

  • 13. Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats.
    Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, Fujita T, Nangaku M.
    J Am Soc Nephrol; 2003 Jul 01; 14(7):1825-32. PubMed ID: 12819242
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat.
    Bao W, Qin P, Needle S, Erickson-Miller CL, Duffy KJ, Ariazi JL, Zhao S, Olzinski AR, Behm DJ, Pipes GC, Jucker BM, Hu E, Lepore JJ, Willette RN.
    J Cardiovasc Pharmacol; 2010 Aug 01; 56(2):147-55. PubMed ID: 20714241
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death.
    Trollmann R, Richter M, Jung S, Walkinshaw G, Brackmann F.
    Neuroscience; 2014 Oct 10; 278():327-42. PubMed ID: 25162122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.